Predicted protein targets (top 2)
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL2292031 | 0.81 | — | — | |
| SCHEMBL2935421 | 0.77 | EIF4E (0.45) | HPRT1NT5E | |
| SCHEMBL29453202 | 0.77 | EIF4E (0.45) | HPRT1NT5E | |
| SCHEMBL3236739 | 0.72 | GSK3B (0.53) | — | |
| SCHEMBL9848321 | 0.71 | MEN1 (0.30) | — | |
| SCHEMBL3134528 | 0.69 | PAX8 (0.33) | — | |
| SCHEMBL5861503 | 0.69 | NT5E (0.60) | NT5E | |
| SCHEMBL4081026 | 0.69 | NT5E (0.60) | NT5E | |
| SCHEMBL16098965 | 0.69 | RAB9A (0.38) | — | |
| SCHEMBL16008962 | 0.69 | RAB9A (0.38) | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 27 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1051504-A2 | RIBOFLAVIN BIOSYNTHESIS GENES FROM PLANTS AND USES THEREOF | Novartis AG (CH) | 2000-11-15 | — | — | EP | claimed |
| WO-1999038986-A2 | RIBOFLAVIN BIOSYNTHESIS GENES FROM PLANTS AND USES THEREOF | NOVARTIS AG (CH) | 1999-08-05 | — | — | WO | claimed |
| US-20230235375-A1 | FERMENTATION PROCESS | DSM IP ASSETS B.V. (NL) | 2023-07-27 | — | — | US | disclosed |
| EP-4168565-A2 | FERMENTATION PROCESS | DSM IP Assets B.V. (NL) | 2023-04-26 | — | — | EP | disclosed |
| CN-115715328-A | Fermentation process | 帝斯曼知识产权资产管理有限公司 | 2023-02-24 | — | — | CN | disclosed |
| US-20220010291-A1 | IMPROVED PRODUCTION OF RIBOFLAVIN | DSM IP ASSETS B.V. (NL) | 2022-01-13 | — | — | US | disclosed |
| WO-2021260057-A2 | FERMENTATION PROCESS | DSM IP ASSETS B.V. (NL) | 2021-12-30 | — | — | WO | disclosed |
| EP-3880835-A1 | IMPROVED PRODUCTION OF RIBOFLAVIN | DSM IP Assets B.V. (NL) | 2021-09-22 | — | — | EP | disclosed |
| CN-113015811-A | Improved riboflavin production | 帝斯曼知识产权资产管理有限公司 | 2021-06-22 | — | — | CN | disclosed |
| WO-2020099303-A1 | IMPROVED PRODUCTION OF RIBOFLAVIN | DSM IP ASSETS B.V. (NL) | 2020-05-22 | — | — | WO | disclosed |
| EP-1814983-B1 | IMPROVED ENZYMES | DSM IP ASSETS BV (NL) | 2013-08-21 | — | — | EP | disclosed |
| US-6551813-B1 | Yeast extract, glucose, a magnesium salt, a manganese salt, a calcium salt, an iron salt, a phosphate buffer, and additional salt selected from the group consisting of a glutamic acid salt, a citric acid salt, and a succinic acid salt | ROCHE VITAMINS INC. | 2003-04-22 | — | — | US | disclosed |
| US-6322995-B1 | RECOMBINANT GRAM POSITIVE BACTERIUM USED FOR PRODUCING RIBOFLAVIN | F. HOFFMANN-LA ROCHE AG (CH) | 2001-11-27 | — | — | US | disclosed |
| EP-1051504-A2 | RIBOFLAVIN BIOSYNTHESIS GENES FROM PLANTS AND USES THEREOF | Novartis AG (CH) | 2000-11-15 | — | — | EP | disclosed |
| EP-0405370-B1 | Riboflavinoverproducing strains of bacteria | HOFFMANN LA ROCHE (CH) | 2000-08-30 | — | — | EP | disclosed |
| EP-1001026-A2 | Riboflavinoverproducing strains of bacteria | F. Hoffmann-La Roche AG (CH) | 2000-05-17 | — | — | EP | disclosed |
| WO-1999038986-A2 | RIBOFLAVIN BIOSYNTHESIS GENES FROM PLANTS AND USES THEREOF | NOVARTIS AG (CH) | 1999-08-05 | — | — | WO | disclosed |
| US-5925538-A | CULTURING RECOMBINANT BACTERIUM HAVING EXOGENOUS NUCLEIC ACID SEQUENCE CODING FOR PROMOTER AND OPEN READING FRAME 3 STRUCTURAL GENE SIMILAR TO A BACILLUS SUBTILIS RIBOFLAVIN OPERON GENE, RECOVERING AT LEAST 10 GRAMS PER LITER | ROCHE VITAMINS INC. (US) | 1999-07-20 | — | — | US | disclosed |
| US-5837528-A | NUCLEOTIDE SEQUENCE OF RIB OPERON AND ITS OPEN READING FRAMES; GENETIC ENGINEERING | HOFFMANN LA ROCHE, INC. (US) | 1998-11-17 | — | — | US | disclosed |
| EP-0405370-A1 | Riboflavinoverproducing strains of bacteria | F. HOFFMANN-LA ROCHE AG (CH) | 1991-01-02 | — | — | EP | disclosed |